Evaluation Of Polypharmacy And Excessive Polypharmacy In Geriatric Inpatients In General Hospital
DOI:
https://doi.org/10.46799/jhs.v5i10.1375Keywords:
Geriatrics, Polypharmacy, Risk Factors, Disease Diagnosis, Excessive PolypharmacyAbstract
Polypharmacy is the simultaneous use of drugs with 5-9 drugs. Excessive polypharmacy is the simultaneous use of drugs with ≥ 10 drugs. Chronic diseases that are commonly suffered by geriatric patients are prone to causing a person to receive polypharmacy or excessive polypharmacy. This study aims to eval_uate polypharmacy and excessive polypharmacy in inpatient geriatric patients, by knowing the factors that may trigger a person to receive polypharmacy. The research uses a cross-sectional study method, using medical record data for the period January to December 2023. The part studied was in the form of sociodemographics, disease history and treatment of patients, as well as length of stay. From the research conducted, the results were obtained from 295 patient data samples with 141 patients (47.8%) and 154 patients (52.5%) were female. The age of patients consisted of 60-74 years old 192 patients (65.1%), 75-90 years old 100 patients (33.9%), and ≥ 90 years 3 patients (1%). The last education of the highest patient with a high school background was 101 patients (34.2%), the highest marital status was married as many as 245 patients (83.1%). The diagnosis of the third disease has the most patients, namely diabetes mellitus as many as 95 patients (15.5%), anemia as many as 70 patients (11.5%), and hypertension as many as 56 patients (9.2%). The preval_ence of polypharmacy in geriatric patients was 115 patients (39%) and excessive polypharmacy was 180 patients (61%). Broadly speaking, the sociodemographics of patients do not have a relationship with the occurrence of polypharmacy and excessive polypharmacy. The patient's clinical condition has a relationship with the occurrence of polypharmacy and excessive polypharmacy, this is evidenced by a p value of 0.000 (<0.05). The length of hospitalization and diagnosis of the patient's disease is a predictor of polypharmacy and excessive polypharmacy.
References
Almodóvar, A. S., & Nahata, M. C. (2019). Associations between chronic disease, polypharmacy, and medication-related problems among medicare beneficiaries. Journal of Managed Care & Specialty Pharmacy, 25(5), 573–577.
Alqahtani, H. M., Koroukian, S. M., Stange, K., Bissada, N. F., & Schiltz, N. K. (2022). Combinations of chronic conditions, functional limitations and geriatric syndromes associated with periodontal disease. Family Medicine and Community Health, 10(3).https://doi.org/10.1136/fmch-2022-001733
Angin, M., Saputri, G., & Fahmi, E. (2023). Evaluation of the Effectiveness of Using Combination Therapy in Hypertensive Patients in Outpatients at Hasanuddin Damrah Regional Hospital. Jurnal Medika Malahayati, 6(4), 434–441. https://doi.org/10.33024/jmm.v6i4.8878
Chang, T. I., Park, H., Kim, D. W., Jeon, E. K., Rhee, C. M., Kalantar-Zadeh, K., Kang, E. W., Kang, S.-W., & Han, S. H. (2020). Polypharmacy, hospitalization, and mortality risk: a nationwide cohort study. Scientific Reports, 10(1), 18964. 10.1038/s41598
Cho, H. J., Chae, J., Yoon, S.-H., & Kim, D.-S. (2022). Aging and the prevalence of polypharmacy and hyper-polypharmacy among older adults in South Korea: a national retrospective study during 2010–2019. Frontiers in Pharmacology, 13, 866318.
Faisal, S., Zairina, E., Nathishuwan, S., Khotib, J., Kristina, S. A., & Nugraheni, G. (2023). Prevalence and predictors of excessive polypharmacy in geriatric inpatients: a retrospective cross-sectional study in Indonesia. Journal of Primary Care & Community Health, 14, 21501319231178596.
Kurniawan, D. E., Kom, M., Afdhol Dzikri, M. T., Irawan, S., & Oktavianto Gustin, M. T. (2020). Sistem Informasi Geografis: Praktikum Dan Penerapan Dalam Pengambilan Keputusan. PolibatamPress.
Mohamed, M. R., Ramsdale, E., Loh, K. P., Xu, H., Patil, A., Gilmore, N., Obrecht, S., Wells, M., Nightingale, G., & Juba, K. M. (2021). Association of polypharmacy and potentially inappropriate medications with physical functional impairments in older adults with cancer. Journal of the National Comprehensive Cancer Network, 19(3), 267–274.
Pazan, F., & Wehling, M. (2021). Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences. European Geriatric Medicine, 12, 443–452.
Santanasto, A. J., Miljkovic, I., Cvejkus, R. C., Gordon, C. L., Bunker, C. H., Patrick, A. L., Wheeler, V. W., & Zmuda, J. M. (2019). Body composition remodeling and incident mobility limitations in African ancestry men. The Journals of Gerontology: Series A, 74(3), 400–405.
Setiati, S., Laksmi, P. W., Aryana, I. G. P. S., Sunarti, S., Widajanti, N., Dwipa, L., Seto, E., Istanti, R., Ardian, L. J., & Chotimah, S. C. (2019). Frailty state among Indonesian elderly: prevalence, associated factors, and frailty state transition. BMC Geriatrics, 19, 1–10.
Soejono, C. H., & Rizka, A. (2021). Polypharmacy and drug use pattern among Indonesian elderly patients visiting emergency unit. Acta Med Indones, 53(1), 60–76.
Styoningsih, R., Amananti, W., & Meliyana, P. (2020). Prescription of Gastritis Drug Use in Outpatients at Syifa Ar-Rachmi Clinic, Slawi. Harapan Bersama Polytechnic of Tegal.
Tanzil, I., Riviati, N., & Saleh, I. (n.d.). Correlation between Polypharmacy and Length of Stay Geriatric Patient in Mohammad Hoesin Palembang Hospital. Jurnal Penyakit Dalam Indonesia, 8(4), 6.
Tseng, C.-H. (2021). The relationship between diabetes mellitus and gastric cancer and the potential benefits of metformin: an extensive review of the literature. Biomolecules, 11(7), 1022. https://doi.org/10.3390/biom11071022
Whitney, D. G., Schmidt, M., & Haapala, H. (2021). Polypharmacy is a risk factor for mortality, severe chronic kidney disease, and liver disease among privately insured adults with cerebral palsy. Journal of Managed Care & Specialty Pharmacy, 27(1), 51–63.
Zahlan, G., De Clifford-Faugère, G., Nguena Nguefack, H. L., Guénette, L., Pagé, M. G., Blais, L., & Lacasse, A. (2023). Polypharmacy and excessive polypharmacy among persons living with chronic pain: a cross-sectional study on the prevalence and associated factors. Journal of Pain Research, 3085–3100. https://doi.org/10.2147/JPR.S411451
Published
Issue
Section
License
Copyright (c) 2024 Erlinda Surya Lita, Ida Paulina Sormin
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under aCreative Commons Attribution-ShareAlike 4.0 International (CC-BY-SA). that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
